Thursday, 19 Jul 2018

You are here

Trump Blasts Drug Makers on the Price of Drugs

Reuter's reports Friday that President Donald Trump blasted drugmakers and healthcare “middlemen” for making prescription drugs unaffordable for Americans. Nonetheless, many healthcare stocks rose as it became clear the administration had avoided taking aggressive and direct measures to cut drug prices.

Here are many New Sources on this developing story:

Reuters:Trump assails high drug prices, avoids direct hit on industry  https://reut.rs/2IBaFiY

Bloomber: Trump's Unimpressive Plan to Lower Drug Prices  https://bloom.bg/2I8tkmO

Financial Times: Trump blames foreign countries for high drug prices  https://on.ft.com/2IdPe4c

NY Times: 6 Takeaways From Trump’s Plans to Try to Lower Drug Prices https://nyti.ms/2IEieFS

          Trump’s Plan to Lower Drug Prices Diverges From Campaign Promise  https://nyti.ms/2wyN65D

           Trump to Drop Call for Medicare to Negotiate Lower Drug Prices  https://nyti.ms/2wAmGR1

Wall St. Journal: Trump’s Plan to Cut Drug Prices Leaves Industry Relieved https://on.wsj.com/2IDeAf6

NPR:  Trump Drug Pricing 'Blueprint' Could Take Years To Build  https://n.pr/2IyMRw5

 

 

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Predictors of Methotrexate Non-Response

New research from a UK study suggests that nonresponse to oral or subcutaneous MTX was seen in 43% and is predicted by seronegativity, higher disease activity measures and higher anxiety scores.

Best of 2017: New EULAR Guidelines on Behçet's

At the EULAR 2016 meeting, new EULAR recommendations for the management of Behçet's disease (BD) were presented. These were developed by a multidisciplinary expert committee that reviewed the evidence from the medical literature and developed final set of 9 recommendations:

EULAR 2018 - Day 3 Report

Day 3 highlights include Behcet’s responds to apremilast and that biologics do not differentially affect TKR/THR post-operative infection rates. Be sure to check out today's podcast as well. 

Canada Closer to Marijuana Approval

Reuters reports that Canada’s Senate on Thursday voted to legalize recreational marijuana, clearing a major hurdle that puts the country on track to become the first Group of Seven nation to permit national use of the drug.

Now the law and amendments go to the House of Commons who will need to decide on before the law can be passed.

Advance Practice Clinicians Proliferating in Specialty Practices

An analysis of SK&A outpatient provider files, covering 90% of physician practices in the United States, shows that between 2008 to 2016, there was a 22% increase in the employment of advanced practice clinicians (APCs) by specialty practices.  By 2016, 28% of all specialty practices employed APCs.